Cargando…
Re-Enlightenment of Fulminant Type 1 Diabetes under the COVID-19 Pandemic
SIMPLE SUMMARY: From 2019, coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spread worldwide and became a serious problem. It is known that various viruses are involved in the development of type 1 diabetes (T1D), but the reports of...
Autores principales: | Sano, Hiroyuki, Imagawa, Akihisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687436/ https://www.ncbi.nlm.nih.gov/pubmed/36421377 http://dx.doi.org/10.3390/biology11111662 |
Ejemplares similares
-
Two types of fulminant type 1 diabetes mellitus: Immune checkpoint inhibitor‐related and conventional
por: Imagawa, Akihisa
Publicado: (2020) -
“Preserved” glucagon secretion in fulminant type 1 diabetes
por: Murase‐Mishiba, Yuko, et al.
Publicado: (2018) -
Pathogenesis of fulminant type 1 diabetes: Genes, viruses and the immune mechanism, and usefulness of patient‐derived induced pluripotent stem cells for future research
por: Hosokawa, Yoshiya, et al.
Publicado: (2019) -
Research following genome‐wide association study focuses on the multifaceted nature of Src kinase‐associated phosphoprotein 2 in type 1 diabetes
por: Sano, Hiroyuki, et al.
Publicado: (2022) -
Antibody to CMRF35-Like Molecule 2, CD300e A Novel Biomarker Detected in Patients with Fulminant Type 1 Diabetes
por: Haseda, Fumitaka, et al.
Publicado: (2016)